Immunologically active phenotype by gene expression profiling is associated with clinical benefit from PD-1/PD-L1 inhibitors in real-world head and neck and lung cancer patients

0 avis

Immunologically active phenotype by gene expression profiling is associated with clinical benefit from PD-1/PD-L1 inhibitors in real-world head and neck and lung cancer patients

Archive ouverte

Edité par CCSD ; Elsevier -

International audience

Langue: en

Consulter en ligne

Consulter le document

Suggestions

Du même auteur

Epithelial-to-mesenchymal transition promotes immune escape by inducing CD70 in non-small cell lung cancer

Archive ouverte | Ortiz-Cuaran, Sandra | CCSD

International audience

Extensive head and neck skin cancers: Carcinologic surgery as a cornerstone of treatment

Archive ouverte | Bondi, Thomas | CCSD

International audience. Background and Objective. The prevalence of extensive skin cancers increases with the aging of the population. Surgical management is the gold standard of curative treatment while morbidity i...

Radiomics combined with transcriptomics to predict response to immunotherapy from patients treated with PD-1/PD-L1 inhibitors for advanced NSCLC

Archive ouverte | Bouhamama, Amine | CCSD

International audience. Introduction In this study, we aim to build radiomics and multiomics models based on transcriptomics and radiomics to predict the response from patients treated with the PD-L1 inhibitor. Mate...

Chargement des enrichissements...